نقش استروئیدهای خوراکی آغاز شده توسط بیمار و والدین برای حملات آسم
Appendices
Appendix 1. Sources and search methods for Cochrane Airways Group's Specialised Register (CAGR)
Electronic searches: core databases
| Database | Frequency of search |
| CENTRAL (Cochrane Library) | Monthly |
| MEDLINE (Ovid) | Weekly |
| Embase (Ovid) | Weekly |
| PsycINFO (Ovid) | Monthly |
| CINAHL (EBSCO) | Monthly |
| AMED (‐Ovid?) | Monthly |
Handsearches: core respiratory conference abstracts
| Conference | Years searched |
| American Academy of Allergy, Asthma and Immunology (AAAAI) | 2001 onwards |
| American Thoracic Society (ATS) | 2001 onwards |
| Asia Pacific Society of Respirology (APSR) | 2004 onwards |
| British Thoracic Society Winter Meeting (BTS) | 2000 onwards |
| Chest Meeting | 2003 onwards |
| European Respiratory Society (ERS) | 1992, 1994, 2000 onwards |
| International Primary Care Respiratory Group Congress (IPCRG) | 2002 onwards |
| Thoracic Society of Australia and New Zealand (TSANZ) | 1999 onwards |
MEDLINE search strategy used to identify trials for the CAGR
Asthma search
1. exp Asthma/
2. asthma$.mp.
3. (antiasthma$ or anti‐asthma$).mp.
4. Respiratory Sounds/
5. wheez$.mp.
6. Bronchial Spasm/
7. bronchospas$.mp.
8. (bronch$ adj3 spasm$).mp.
9. bronchoconstrict$.mp.
10. exp Bronchoconstriction/
11. (bronch$ adj3 constrict$).mp.
12. Bronchial Hyperreactivity/
13. Respiratory Hypersensitivity/
14. ((bronchial$ or respiratory or airway$ or lung$) adj3 (hypersensitiv$ or hyperreactiv$ or allerg$ or insufficiency)).mp.
15. ((dust or mite$) adj3 (allerg$ or hypersensitiv$)).mp.
16. or/1‐15
Filter to identify randomised controlled trials (RCTs)
1. exp "clinical trial [publication type]"/
2. (randomized or randomised).ab,ti.
3. placebo.ab,ti.
4. dt.fs.
5. randomly.ab,ti.
6. trial.ab,ti.
7. groups.ab,ti.
8. or/1‐7
9. Animals/
10. Humans/
11. 9 not (9 and 10)
12. 8 not 11
The MEDLINE strategy and RCT filter are adapted to identify trials in other electronic databases.
Appendix 2. Search strategy to identify relevant trials from the CAGR
#1 AST:MISC1
#2 MeSH DESCRIPTOR Asthma Explode All
#3 asthma*:ti,ab
#4 #1 or #2 or #3
#5 prednis*
#6 methylprednis*
#7 dexamethasone
#8 cortisone
#9 hydrocortisone*
#10 medrol
#11 solumedrol
#12 solu‐medrol
#13 betamethasone
#14 triamcinolone
#15 (oral* or systemic*) near3 (steroid* or corticosteroid* or glucocorticoid*)
#16 OCS:ti,ab
#17 #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 or #16
#18 MeSH DESCRIPTOR Patient Participation
#19 MeSH DESCRIPTOR Decision Making
#20 (patient* or parent* or caregiver* or career*) NEAR (initiat* or suggest* or instigat* or originat* or request* or propose* or encourage* or advocate*)
#21 self‐refer* or self NEXT refer*
#22 #18 or #19 or #20 or #21
#23 #4 AND #17 AND #22
#24 (#23) AND (INREGISTER)
(Note: in search line #1, MISC1 denotes the field in the record where the reference has been coded for condition, in this case, asthma)
Study flow diagram.
| Patient‐initiated steroids compared with placebo/normal care/alternative active treatment for asthma | ||
| Patient or population: adults aged 18 years or older with asthma Settings: outpatient Intervention: patient‐initiated oral corticosteroids Comparison: placebo/normal care/alternative active treatment | ||
| Outcomes | Number of participants | Comments |
| Hospital admissions for asthma | 0 (0 studies) | No studies met the inclusion criteria for this review |
| Asthma control (validated scales) | 0 (0 studies) | |
| Serious adverse events (all cause) | 0 (0 studies) | |
| Unscheduled visit to a healthcare provider | 0 (0 studies) | |
| Health‐related quality of life (validated scales) | 0 (0 studies) | |
| Days lost of study/work | 0 (0 studies) | |
| Adverse events (all cause) | 0 (0 studies) | |
| GRADE Working Group grades of evidence | ||
| Parent‐initiated steroids compared with placebo/normal care/alternative active treatment for asthma | ||
| Patient or population: children aged 5 years or older with asthma Settings: outpatient Intervention: parent‐initiated oral corticosteroids Comparison: placebo/normal care/alternative active treatment | ||
| Outcomes | Number of participants | Comments |
| Hospital admissions for asthma | 0 (0 studies) | No studies met the inclusion criteria for this review |
| Asthma control (validated scales) | 0 (0 studies) | |
| Serious adverse events (all cause) | 0 (0 studies) | |
| Unscheduled visit to a healthcare provider | 0 (0 studies) | |
| Health‐related quality of life (validated scales) | 0 (0 studies) | |
| Days off school | 0 (0 studies) | |
| Adverse events (all cause) | 0 (0 studies) | |
| GRADE Working Group grades of evidence | ||
